Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration
Authors:
Open Access
- 3 May 2022
- journal article
- review article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 117 (1) , 1-18
Abstract
Myocardial injury often leads to heart failure due to the loss and insufficient regeneration of resident cardiomyocytes. The low regenerative potential of the mammalian heart is one of the main drivers of heart failure progression, especially after myocardial infarction accompanied by large contractile muscle loss. Preclinical therapies for cardiac regeneration are promising, but clinically still missing. Mammalian models represent an excellent translational in vivo platform to test drugs and treatments for the promotion of cardiac regeneration. Particularly, short-lived mice offer the possibility to monitor the outcome of such treatments throughout the life span. Importantly, there is a short period of time in newborn mice in which the heart retains full regenerative capacity after cardiac injury, which potentially also holds true for the neonatal human heart. Thus, in vivo neonatal mouse models of cardiac injury are crucial to gain insights into the molecular mechanisms underlying the cardiac regenerative processes and to devise novel therapeutic strategies for the treatment of diseased adult hearts. Here, we provide an overview of the established injury models to study cardiac regeneration. We summarize pioneering studies that demonstrate the potential of using neonatal cardiac injury models to identify factors that may stimulate heart regeneration by inducing endogenous cardiomyocyte proliferation in the adult heart. To conclude, we briefly summarize studies in large animal models and the insights gained in humans, which may pave the way toward the development of novel approaches in regenerative medicine.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB TRR267, SFB TRR267)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01KL1903)
- Austrian Science Fund (I 4161-B)
- Medizinische Hochschule Hannover (MHH)
This publication has 105 references indexed in Scilit:
- Heart repair by reprogramming non-myocytes with cardiac transcription factorsNature, 2012
- In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytesNature, 2012
- MicroRNA therapeutics in cardiovascular medicineEMBO Molecular Medicine, 2011
- Transient Regenerative Potential of the Neonatal Mouse HeartScience, 2011
- Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferationNature, 2010
- Gata4 and Gata5 Cooperatively Regulate Cardiac Myocyte Proliferation in MiceJournal of Biological Chemistry, 2010
- microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heartGenes & Development, 2008
- Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injuryNature Medicine, 2007
- Adult bone marrow–derived cells: Regenerative potential, plasticity, and tissue commitmentBasic Research in Cardiology, 2005
- GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5Nature, 2003